Dr. Kang is a pioneer in the clinical treatment of intervertebral disc degeneration. He has headed the development of novel therapies for IDD using gene transfer and stem cell technologies.
Dr. Kang earned his medical degree from the University of Oklahoma School of Medicine in Oklahoma City. Following medical school, Dr. Kang underwent his orthopedic surgery residency at the University of Pittsburgh Medical School. He then completed his spine surgery fellowship at Case Western Reserve University in Cleveland.
More articles on spine leaders:
Spine surgeon leader to know: Dr. Arien Smith of NYC Surgical Associates
Spine surgeon leader to know: Dr. Justin Park of Mercy Medical Center
Spine surgeon leader to know: Dr. Charles Theofilos of The Spine Center
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.